mhealth israel_merck's digital strategy in africa_alexander hoffmann
TRANSCRIPT
Digital Health in Africa
Merck’s digital strategy in Africa
Alexander Hoffmann | CEO Office | June 2015
Agenda
2
About Merck1
2 Africa – the controversial continent
Innovation in Africa3
4 Merck‘s existing digital projects in Africa
Merck‘s strategy and future outlook5
Agenda
3
About Merck1
2 Africa – the controversial continent
Innovation in Africa3
4 Merck‘s existing digital projects in Africa
Merck‘s strategy and future outlook5
4
Founded in 1668
66 countries
over 39,000 employees
€1.5 billion invested in R&D in 2013
€11.1 billion total revenues in 2013
Healthcare, Life Science, Performance Materials
Performance MaterialsLife ScienceHealthcare
What we do
5
Merck Serono Consumer Health Allergopharma Biosimilars
Prescription medicines to treat, for example, cancer, multiple sclerosis and infertility, over-the-counter pharmaceuticals for everyday health protection or to provide fast relief of colds and pain, as well as innovations in the areas of allergies and biosimilars.
Merck Millipore
Innovative tools and laboratory supplies for the life science industry that make research and biotech production easier, faster and more successful.
Performance Materials
A wide range of specialty chemicals, such as liquid crystals for displays, effect pigments for coatings and cosmetics, or high-tech materials for the electronics industry.
Nearly 350 years of experience for patients and customers
Friedrich Jacob Merck purchases the "Angel Pharmacy" (Engel-Apotheke) in Darmstadt
Emanuel Merck begins pro-duction on an industrial scale
Merck is represented on all continents
Our U.S. subsidiary Merck & Co. is expropriated as a consequence of World War I
Merck loses its subsidiaries abroad and starts up again from the ruins in Darmstadt
Merck subsidiaries are founded or reestablished around the world
Merck enters the field of biotechnology, assuming a pioneering role in Germany
The Merck Institute for Experimental Drug Research is established
Initial public offering
Acquisition of Serono
Acquisition of Millipore
Merck takes up the fight against schistosomiasis, aiming to elim-inate this tropical disease in Africa
Annual sales exceed € 10 bn for the first time
Merckmarks its 350th anniversary
1668 1827 1900 1917 1945 1950/60 1955 1969 1995 2007 2010 2011 2012 2018
Unternehmenspräsentation | 05 März 20146
We are Merck – the originalIn 1887, Merck opened its own office in New York, which gave rise to the subsidiary Merck & Co.
three years later. As a result of World War I, this subsidiary was expropriated in 1917 and has been an independent company ever since 1917. Merck – the original – holds the global rights to the Merck name and brand.
Exceptions are Canada and the United States, where we are known under the EMD brand, which stands for "Emanuel Merck Darmstadt“.
Agenda
9
About Merck1
2 Africa – the controversial continent
Innovation in Africa3
4 Merck‘s existing digital projects in Africa
Merck‘s strategy and future outlook5
Africa – controversial continent
Presentation title in footer | 00 Month 000012
1.13 billion people in 20151.45 billion people in 2025
2.3 billion people in 2050
Sources: http://africacheck.org/factsheets/factsheet-africas-population-projections/ http://www.worldbank.org/en/region/afr/overview
http://techcrunch.com/2014/02/08/in-3-5-years-most-africans-will-have-smartphones/http://
www.theguardian.com/world/2014/jun/05/internet-use-mobile-phones-africa-predicted-increase-20-fold
5.5% GDP growth overall Africa (excl. South Africa)
Today, 18% of all Africans have smartphones
Expected to increase 20-fold in the next 5 years
D E V E L O P M E N T O F D I A B E T E S C A S E S I N
A F R I C A
Diabetes in Africa – a growing issue
13
2035
20m
+110%
42m
2013
*Source: IDF Diabetes Atlas, Sixth Edition, International Diabetes Federation
„9% of deaths in African region can be attributed to
diabetes.“
„Overall prevalence of diabetes in Africa is at 4.9% of the
population. In Kenya alone this results in more than 2m cases.“
Agenda
14
About Merck1
2 Africa – the controversial continent
Innovation in Africa3
4 Merck‘s existing digital projects in Africa
Merck‘s strategy and future outlook5
Agenda
16
About Merck1
2 Africa – the controversial continent
Innovation in Africa3
4 Merck‘s existing digital projects in Africa
Merck‘s strategy and future outlook5
What Merck is already doing
17
ONLINE & MOBILE PLATFORM FOR DOCTORS
ONLINE & MOBILE DIABETES RISK ASSESSMENT
MOBILE APP FOR DIABETES PATIENTS
What is it?
18 *based on the Finnish Diabetes Risk Score (FINDRISC)
Questionnaire that calculates your risk of developing diabetes*
Available on desktop computers, smartphones and tablets (with USSD functionality to follow)
Goal to raise awareness about the prevention, diagnosis and treatment of diabetes
Free of charge for the user
Provides clear call to action for the user and a free blood testing at the nearest pharmacy
Some results…
20
12 13 14 15 16 17 18 19 20 21 22 23 24 250
1000
2000
3000
4000
5000
6000
22 50377 539 603 723 819
11021500
1979
2611
3360
4351
5503
5 11 49 78 86 117 135 178 241 328 441 554 712977
Development
Gender
Female Male
Age groups
Under 45 45-54
55-64 Over 65
risk groups
Low risk Slightly elevated risk
Moderate risk High risk
Very high risk
What Merck is already doing
21
ONLINE & MOBILE PLATFORM FOR DOCTORS
ONLINE & MOBILE DIABETES RISK ASSESSMENT
MOBILE APP FOR DIABETES PATIENTS
Support to MobiDawa
Merck Diabetes Risk Assessment Questionnaire | 201522
Sponsoring of Ampion Venture Bus
Identification of high potential startup MobiDawa
Official partnership between Merck and MobiDawa
Support mainly through network sharing and consulting
Benefit for MobiDawa and Merck
Agenda
23
About Merck1
2 Africa – the controversial continent
Innovation in Africa3
4 Merck‘s existing digital projects in Africa
Merck‘s strategy and future outlook5
Merck‘s digital strategy in Africa
24
Internal digital projects for own product support
(marketing)
External innovation
support through startup
acceleration
Hack for big choices logo
YOU?
Startup acceleratio
n image